• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝血酶III:用发色底物(发色底物TH)测得的参考值(作者译)

[Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)].

作者信息

Hesse R, Tritschler W, Castelfranchi G, Bablok W

出版信息

Blut. 1981 Apr;42(4):227-34. doi: 10.1007/BF00996752.

DOI:10.1007/BF00996752
PMID:7225580
Abstract

A new kinetic assay for antithrombin III (heparin-cofactor) in plasma was used to determine reference values. Ranges of 10--15 IU/ml at 25 degrees C and 20--29 IU/ml at 37 degrees C were found for a reference population of 219 men and 204 women 15--93 years of age. There was no evidence that these values vary with age or sex, nor was there any difference between pre- and postprandial antithrombin activities, or between smokers' and non-smokers' values. None of the illnesses present in the reference population nor any related drug therapy affected the antithrombin III level, and there was no statistically significant difference between the values for women taking oral contraceptives and those who did not. However, this latter observation does not preclude the possibility of individual variation.

摘要

采用一种新的血浆抗凝血酶III(肝素辅因子)动力学测定法来确定参考值。在15至93岁的219名男性和204名女性参考人群中,发现25摄氏度时的参考值范围为10 - 15国际单位/毫升,37摄氏度时为20 - 29国际单位/毫升。没有证据表明这些值随年龄或性别而变化,餐后抗凝血酶活性在餐前和餐后之间也没有差异,吸烟者和非吸烟者的值之间也没有差异。参考人群中存在的任何疾病或任何相关药物治疗均未影响抗凝血酶III水平,服用口服避孕药的女性和未服用口服避孕药的女性的值之间也没有统计学上的显著差异。然而,后一种观察结果并不排除个体差异的可能性。

相似文献

1
[Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)].抗凝血酶III:用发色底物(发色底物TH)测得的参考值(作者译)
Blut. 1981 Apr;42(4):227-34. doi: 10.1007/BF00996752.
2
Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex.血浆中肝素辅因子活性及抗凝血酶III浓度与年龄和性别的关系。
Scand J Haematol. 1976 Oct;17(4):258-62. doi: 10.1111/j.1600-0609.1976.tb01183.x.
3
Measurement of antithrombin activity by thrombin-based and by factor Xa-based chromogenic substrate assays.通过基于凝血酶和基于因子Xa的显色底物测定法测量抗凝血酶活性。
Blood Coagul Fibrinolysis. 2000 Mar;11(2):127-35.
4
Two automated methods for plasma antithrombin III compared, and the clinical significance of the results.两种血浆抗凝血酶III自动化检测方法的比较及其结果的临床意义。
Clin Chem. 1982 Nov;28(11):2249-53.
5
[Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency].[马的抗凝血酶III测定。参考值及获得性抗凝血酶III缺乏症]
Tierarztl Prax. 1987;15(1):47-55.
6
[Oral contraceptive agents and antithrombin III].[口服避孕药与抗凝血酶III]
Akush Ginekol (Sofiia). 1990;29(1):60-3.
7
Heparin cofactor II levels are increased by the use of combined oral contraceptives.联合使用口服避孕药会使肝素辅因子II水平升高。
Blood Coagul Fibrinolysis. 1990 Dec;1(6):647-51.
8
Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition.抗凝血酶III、肝素辅因子与抗Xa因子水平与年龄、性别及病理状况的关系
Haemostasis. 1980;9(5):297-302. doi: 10.1159/000214368.
9
[Assay of antithrombin III activity using chromogenic substrate (author's transl)].用发色底物法测定抗凝血酶III活性(作者译)
Rinsho Byori. 1982 Jan;30(1):54-8.
10
A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).一种使用新型合成肽底物(PS-915)检测血浆抗凝血酶III的比色测定法。
Clin Chim Acta. 1984 Dec 29;144(2-3):163-71. doi: 10.1016/0009-8981(84)90050-0.

引用本文的文献

1
Antithrombin III deficiency in ischaemic stroke.
Klin Wochenschr. 1983 Jun 15;61(12):617-20. doi: 10.1007/BF01487340.
2
[Predictor function of hemorheologic parameters with reference to the incidence of manifest circulatory disorders: Concept of the Aachen study].
Klin Wochenschr. 1986 Jul 15;64(14):653-62. doi: 10.1007/BF01726918.
3
Hormone replacement therapy and its influence on AT-III activity in climacteric women.激素替代疗法及其对更年期女性抗凝血酶III活性的影响。
Klin Wochenschr. 1991 Mar 18;69(5):232. doi: 10.1007/BF01646949.
4

本文引用的文献

1
Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.服用口服避孕药的女性中抗凝血酶Ⅲ降低及凝血酶生成加速。
Am J Obstet Gynecol. 1971 Mar 15;109(6):868-73. doi: 10.1016/0002-9378(71)90799-x.
2
Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration.人抗凝血酶3的免疫学研究。年龄、性别及口服避孕药的使用对血清浓度的影响。
Scand J Haematol. 1970;7(1):10-7.
3
Inactivation of antithrombin 3 by fatty acids.脂肪酸对抗凝血酶3的灭活作用。
Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.正常女性接受他莫昔芬治疗期间的止血变化及血栓栓塞风险
Br J Cancer. 1992 Oct;66(4):744-7. doi: 10.1038/bjc.1992.350.
Hoppe Seylers Z Physiol Chem. 1972 Dec;353(12):1957-61. doi: 10.1515/bchm2.1972.353.2.1957.
4
Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity.复方雌激素 - 孕激素口服避孕药、雌激素和孕激素对抗纤溶酶及抗凝血酶活性的影响。
Lancet. 1970 Dec 26;2(7687):1329-32. doi: 10.1016/s0140-6736(70)92358-5.
5
[Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].接受雌激素、孕激素及雌激素 - 孕激素避孕药的女性的血液凝固与纤维蛋白溶解(作者译)
Klin Wochenschr. 1976 May 1;54(9):431-8. doi: 10.1007/BF01470929.
6
Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome.正常受试者、家族性高脂血症患者及肾病综合征患者进食高脂餐后的抗凝血酶功能活性
J Lab Clin Med. 1977 Sep;90(3):529-35.
7
[Surveillance of women taking oral contraceptives by determination of antithrombin III].
Nouv Presse Med. 1979 Feb 10;8(7):528-9.
8
Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex.血浆中肝素辅因子活性及抗凝血酶III浓度与年龄和性别的关系。
Scand J Haematol. 1976 Oct;17(4):258-62. doi: 10.1111/j.1600-0609.1976.tb01183.x.